急性扩展型A型主动脉夹层预防性TEVAR并无必要
本研究比较急性扩展型A型(DeBakey I型)夹层行升主动脉修复后与急性B型夹层的疾病进展和干预需求。中期结果提示ExTA夹层升主动脉修复后预防性TEVAR并不合理。
要点
- ExTA夹层升主动脉修复后仅12%需TEVAR,远低于B型夹层的66%
- ExTA组88%无需干预,其中53%无疾病进展
- B型夹层干预/进展无生存显著劣于ExTA(log rank P < .001)
核心结论
- 急性ExTA夹层升主动脉修复后,约半数胸腹主动脉无疾病进展,仅少数需额外干预。
- 与B型夹层不同,ExTA夹层升主动脉修复后预防性TEVAR似乎并不合理。
研究设计与样本
- 回顾性队列研究,连续纳入2011至2018年就诊的ExTA或B型夹层患者。
主要发现
- ExTA组升主动脉修复后5例(12%)在出院后4个月内行TEVAR。
- B型组29例(66%)行早期或晚期TEVAR(P < .001)。
- 平均随访38±30个月,ExTA组38例(88%)无需干预,其中23例(53%)无疾病进展。
- B型组平均随访18±6个月,14例(32%)无需干预,其中9例(20%)无疾病进展(P = .003)。
- ExTA组1例主动脉相关晚期死亡,B型组2例;B型组无干预生存和免干预/进展生存显著更差(log rank P < .001)。
临床怎么用
- 急性ExTA夹层升主动脉修复后,不推荐常规预防性TEVAR。
- 对ExTA夹层患者应注重优化药物治疗和影像随访,而非预防性腔内干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pre-emptive thoracic endovascular aortic repair (TEVAR) improves late survival and limits progression of disease after type B aortic dissection, but the potential value of pre-emptive TEVAR has not been evaluated after type A dissection extending beyond the aortic arch (DeBakey type I). The purpose of this study was to compare disease progression and need for aortic intervention in survivors of acute, extended type A (ExTA) dissections after initial repair of the ascending aorta versus acute type B aortic dissections. METHODS: Consecutive patients presenting with ExTA or type B dissections between 2011 and 2018 were studied. Forty-three patients with ExTA and 44 with type B dissections who survived to discharge and had follow-up imaging studies were included in the analysis. Study end points included progression of aortic disease (>5 mm growth or extension), need for intervention, and death. RESULTS: The groups were not different for age, sex, atherosclerotic risk factors, or extent of dissection distal to the left subclavian artery. Following emergent ascending aortic repair, five ExTA patients (12%) underwent TEVAR within 4 months after discharge. Despite optimal medical treatment, 29 type B patients (66%) underwent early or late TEVAR (P < .001). During a mean follow-up of 38 ± 30 months, 38 ExTA patients (88%) did not require intervention-23 (53%) of whom showed no disease progression. In comparison, during a mean follow-up of 18 ± 6 months, 14 type B patients (32%) did not require intervention-nine (20%) of whom showed no disease progression (P = .003). There was one aortic-related late death in the ExTA group and two in the type B group. Compared with ExTA patients, type B patients had significantly worse intervention-free survival and intervention/growth-free survival (log rank, P < .001). CONCLUSIONS: In contrast with type B dissections, these midterm results demonstrate that one-half of ExTA aortic dissections show no disease progression in the thoracic or abdominal aorta, and few require additional interventions. After initial repair of the ascending aorta, pre-emptive TEVAR does not seem to be justified in patients with acute, ExTA dissections.
引用
- Reed AB, Self P, Rosenberg M, et al. Pre-emptive thoracic endovascular aortic repair is unnecessary in extended type A (DeBakey type I) aortic dissections. J Vasc Surg. 2020. PMID: 32035774. doi:10.1016/j.jvs.2019.11.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。